Silvestre FJ, Silvestre-Rangil J, Bagan L, Bagan JV. Effect of
nonsurgical periodontal treatment in patients with periodontitis and rheumatoid arthritis: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 May 1;21
(3):e349-54.
doi:10.4317/medoral.20974
http://dx.doi.org/doi:10.4317/medoral.20974
|
1.
Linden GJ, Lyons A, Scannapieco
FA. Periodontal systemic associations:
review of the evidence. J Clin Periodontol. 2013;40 Suppl.14:S8-19. |
|
|
|
|
|
2.
Loyola-Rodriguez JP, Martinez-Martinez
RE, Abud-Mendoza C, Pati-o-Marin N, Seymour GJ. Rheumatoid
arthritis and the role of
oral bacteria. J Oral Microbiol. 2010;2:5784. |
|
|
|
|
|
3. Weyand CM. New insights into the pathogenesis
of rheumatoid arthritis. Rheumatology (Oxford). 2000;39 Suppl
1:3-8. |
|
|
|
|
|
4. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990;33:305-15. |
|
|
|
|
|
5. Kobayashi T, Murasawa A, Komatsu Y, Yokoyama T, Ishida K, Abe A, et al. Serum cytokine and periodontal profiles
in relation to disease activity of rheumatoid arthritis in Japanese adults. J Periodontol. 2010;81:650-7. |
|
|
|
|
|
6. Ishida K, Kobayashi T, Ito S, Komatsu Y, Yokoyama T, Okada M, et al.
Interleukin-6 gene promoter methylation
in rheumatoid arthritis
and chronic periodontitis. J Periodontol.
2012;83:917-25. |
|
|
|
|
|
7. Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD.
Anti-citrullined peptides
as autoantigens in rheumatoid
arthritis- relevance to treatment. Autoimmun Rev. 2014;13:114-20. |
|
|
|
|
|
8. Konig MF, Paracha AS, Moni M, Bingham CO, Andrade F. Defining
the role of Porphyromonas
gingivalis peptidylarginine
deiminase (PPAD) in rheumatoid
arthritis through the study of PPAD biology. Ann Rheum Dis. 2015;74:2054-61. |
|
|
|
|
|
9. Mikuls TR, Paune JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, et al. Periodontitis and Porphyromonas
gingivalis in patients with rheumatoid arthritis. Arthritis Reumatol. 2014;66:1090-100. |
|
|
|
|
|
10.
Wolfe F. Comparative usefulness
of C-reactive protein and erythrocyte
sedimentacin rate in patients
with rheumatoid arthritis. J Rheumatol.
1997;24:1477-85. |
|
|
|
|
|
11.
Ribeiro J, Leo A, Novaes
AB. Periodontal infection as a posible severity factor for rheumatoid arthritis. J Clin Periodontol.
2005;32:412-6. |
|
|
|
|
|
12.
Al-katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD. Control of periodontal infection
reduces the severity of
active rheumatoid arthritis.
J Clin Rheumatol.
2007;13:134-7. |
|
|
|
|
|
13.
Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, et
al. Periodontal therapy reduces the
severity of active rheumatoid
arthritis in patients treated with or without tumor necrosis
factor inhibitors. J Periodontol.
2009;80:535-40. |
|
|
|
|
|
14. Pinho MN, Oliveira RD, Novaes
AB Jr, Voltarelli JC. Relationship between
periodontitis and rheumatoid arthritis
and the effect of non-surgical periodontal treatment.
Braz Dent J.
2009;20:355-64. |
|
|
|
|
|
15. Ranade SB, Doiphode S. Is there a relationship
between periodontitis and rheumatoid
arthritis?. J Indian Soc Periodontol. 2012;16:22-7. |
|
|
|
|
|
16. Okada M, Kobayashi T, Ito S, Yokoyama T, Abe A, Murasawa A, et al. Periodontal treatment
decreases levels of antibodies to Prophyromonas gingivalis and citrulline in patients with reumatoid arthritis and periodontitis. J Periodontol.
2013;84:e74-84. |
|
|
|
|
|
17. Biyikoğlu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoğlu E,
et al. Periodontal therapy in chronic
periodontitis lowers gingival crevicular
fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int. 2013;33:2607-16. |
|
|
|
|
|
18. Monsarrat P, Vergnes JN, Cantagrel A, Algans N, Cousty S, Kmoun P, et al. Effect of periodontal treatment
on the clinical parameters of patients with rheumatoid arthritis: study protocol of the randomized, controlled ESPERA trail. Trials. 2013;14:253. |
|
|
|
|
|
19. Kaur S, Bright R, Proudman SM, Bartold PM. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis?. A systematic review and meta-analysis. Semin Arthritis Rheum.
2014;44:113-22. |
|
|
|
|
|
20. Hajishengallis G, Moutsopoulos
NM. Etiology of leukocyte
adhesin deficiency-associated periodontitis revisited: not a raging infection but a raging inflammatory response. Expert Rev Clin Immunol.
2014;10:973-5. |
|
|
|
|
|
21. Hajishengallis G. The inflammophilic carcter of the
periodontitis-associated microbiota.
Mol Oral Microbiol. 2014;29:248-57. |
|
|
|
|
|
22. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstrm
V, Feldmann M, et al. Autoimmunity
to specific citrullinated proteins gives the first
clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010;233:34-54. |
|
|
|
|
|
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The
American Rheumatism Association
1987 revised criteria for the classification
of rheumatoid arthritis. Arthritis Rheum.
1988;31:315-24. |
|
|
|
|
|
24.
Haro I, Gmara MJ. The
use of citrullinated peptides
for the diagnosis and
prognosis of rheumatoid arthritis.
Curr Top Med Chem. 2014;14:2729-33. |
|
|
|
|
|
25. Hsu PC, Liao YF, Lin CL, Lin WH, Liu GY, Hung HC. Vimentin is involved
in peptidylarginine 2-induced apoptosis of activated Jurkat cells. Mol Cells.
2014;37:426-34. |
|
|
|
|
|
26. Sos L, Szekanecz Z, Szab Z, Fekete A, Zeher M, Horvth IF, et al. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol. 2007;34:1658-63. |
|
|
|
|
|
27. Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD.
Anti-citrullinated peptides
as autoantigens in rheumatoid
arthritis-relevance to treatment. Autoimmun Rev.
2014;13:1114-20. |
|
|
|
|
|
28. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes:genes, features and involvement in disease. Bioessays.
2003;25:1106-18. |
|
|
|
|
|
29. Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C.
Ca2+-dependent deimination-induced
disassembly of intermediate
filaments involves specific modification of the amino-terminal head domain.
J Biol Chem.
1989;264:18119-27. |
|
|
|
|
|
30. Auger I, Balandraud N, Rak J, Lambert N, Martin M, Roudier
J. New autoantigens in rheumatoid
arthritis (RA). Screening
8268 proteins arrays with ser from patients with RA. Ann Rheum Dis. 2009;68:591-4. |
|
|
|
|
|
31. Masson-Bessire C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent
C, Senshu T, et al. The major sinovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies
are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177-84. |
|
|
|
|
|
32. Serre G. Autoantibodies to filaggrin/deiminated fibrin (AFA) are useful for the
diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease. Joint Bone Spine. 2001;68:103-5. |
|